Search - tctmd.com

Displaying 141 - 160 of 2954

Sort: Relevancy | Date

Presentation TCT 2024

Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial

Presenter: Ulf Teichgräber

October 29, 2024

Presentation TCT 2024

Balancing Clinical Outcomes with Utilization in Clinical Practice - Case Example = The Agent ISR DCB

Presenter: Robert Yeh

October 29, 2024

Presentation TCT 2024

TCT 495: The Impact of Cutting Balloon Pre-Dilation on the Outcomes of Paclitaxel Drug-Coated Balloon Treatment for Coronary In-Stent Restenosis

Presenter: Yuanji Ma

October 29, 2024

Presentation TCT 2024

TCT 432: Long-Term Outcomes of Ultrathin Struts Biodegradable Polymer Sirolimus-Eluting Stent for Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Bernardo Cortese

October 29, 2024

Presentation TCT 2024

TCT 99: Contemporary Utilisation of Guide Catheter Extensions in Percutaneous Coronary Intervention: Lessons From a Single Centre Experience

Presenter: Yeela Talmor Barkan

October 29, 2024

Presentation TCT 2024

TCT 496: Long-term Clinical Outcomes of Drug-Coated Balloons for the Treatment of In-Stent Chronic Total Occlusions

Presenter: Jiasheng Yin

October 29, 2024

Presentation TCT 2024

TCT 494: Between a Stent and a Hard Place: Insights Into Percutaneous Coronary Interventions and In-Stent Restenosis in Cancer Patients

Presenter: Teodora Donisan

October 29, 2024

Presentation TCT 2024

TCT 430: Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating in the Treatment of Native Coronary Artery Lesions: Inspiron Real Life II and Latitude Trials

Presenter: Paulo Caramori

October 29, 2024

Presentation TCT 2024

TCT 429: Percutaneous Coronary Intervention With Ridaforolimus-Eluting-Stents in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis

Presenter: Edmundo Damiani Bertoli

October 29, 2024

Presentation TCT 2024

TCT 428: Efficacy and Safety of a Novel Ultra-Thin Arsenic Trioxide-Tacrolimus Eluting Stent in Porcine Coronary Artery

Presenter: Han Chen

October 29, 2024

Presentation TCT 2024

TCT 493: Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials

Presenter: Michael Sabina

October 29, 2024

Presentation TCT 2024

TCT 785: Post-Procedural Patient-Reported Outcomes and Quality of Life Is Worse in Women Than Men Despite Similar Post-PCI VFFR Values

Presenter: Karol Sadowski

October 29, 2024

Presentation TCT 2024

TCT 497: Sex-Specific Clinical Outcomes After Treatment of In-Stent Restenosis With the AGENT Paclitaxel-Coated Balloon: A Subgroup Analysis of the AGENT IDE Randomized Trial

Presenter: Jennifer Tremmel

October 29, 2024

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

TCT 1322: Neoatherosclerosis After Drug-Coated Balloon Treated In-Stent Restenosis

Presenter: Leonardo Sinnott Silva

October 29, 2024

Presentation TCT 2024

TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

Presenter: Han Chen

October 29, 2024

News Conference News TCT 2024

DRAMI: No Clear Winner for Distal vs Traditional Radial Access in STEMI

Todd Neale

October 29, 2024

Presentation TCT 2024

Designing Future RCTs in PAD Intervention to Meaningfully Change Hard Endpoints - The "Just Give It" Approach

Presenter: Marc Bonaca

October 29, 2024

Presentation TCT 2024

TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent

Presenter: Michael Joner

October 29, 2024

Presentation TCT 2024

TCT 424: Pathological Analysis of Fibrin Deposition Around Stent Struts Within 1 Month After Circumferentially Coated Durable Polymer Drug-Eluting Stents and Abluminally Coated Biodegradable Polymer Drug-Eluting Stents for ACS

Presenter: Kazuki Aihara

October 29, 2024

Advertisement

Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial

Balancing Clinical Outcomes with Utilization in Clinical Practice - Case Example = The Agent ISR DCB

TCT 495: The Impact of Cutting Balloon Pre-Dilation on the Outcomes of Paclitaxel Drug-Coated Balloon Treatment for Coronary In-Stent Restenosis

TCT 432: Long-Term Outcomes of Ultrathin Struts Biodegradable Polymer Sirolimus-Eluting Stent for Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

TCT 99: Contemporary Utilisation of Guide Catheter Extensions in Percutaneous Coronary Intervention: Lessons From a Single Centre Experience

TCT 496: Long-term Clinical Outcomes of Drug-Coated Balloons for the Treatment of In-Stent Chronic Total Occlusions

TCT 494: Between a Stent and a Hard Place: Insights Into Percutaneous Coronary Interventions and In-Stent Restenosis in Cancer Patients

TCT 430: Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating in the Treatment of Native Coronary Artery Lesions: Inspiron Real Life II and Latitude Trials

TCT 429: Percutaneous Coronary Intervention With Ridaforolimus-Eluting-Stents in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis

TCT 428: Efficacy and Safety of a Novel Ultra-Thin Arsenic Trioxide-Tacrolimus Eluting Stent in Porcine Coronary Artery

TCT 493: Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials

TCT 785: Post-Procedural Patient-Reported Outcomes and Quality of Life Is Worse in Women Than Men Despite Similar Post-PCI VFFR Values

TCT 497: Sex-Specific Clinical Outcomes After Treatment of In-Stent Restenosis With the AGENT Paclitaxel-Coated Balloon: A Subgroup Analysis of the AGENT IDE Randomized Trial

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

TCT 1322: Neoatherosclerosis After Drug-Coated Balloon Treated In-Stent Restenosis

TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

DRAMI: No Clear Winner for Distal vs Traditional Radial Access in STEMI

Designing Future RCTs in PAD Intervention to Meaningfully Change Hard Endpoints - The "Just Give It" Approach

TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent

TCT 424: Pathological Analysis of Fibrin Deposition Around Stent Struts Within 1 Month After Circumferentially Coated Durable Polymer Drug-Eluting Stents and Abluminally Coated Biodegradable Polymer Drug-Eluting Stents for ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content